Personalised RNA Interference to Enhance the Delivery of Individualised Cytotoxic and Targeted therapeutics
PREDICT will define the next generation of predictive biomarkers through the integration of clinical trial design with functional cancer genomics to enable personalised medicine and the cost-effective delivery of beneficial cancer therapeutics.
|PREDICT Sponsored Studies|
* = Closed to recruitment
Accession codes: Gene expression microarray data have been deposited in the Gene Expression Omnibus (GEO) archive under accession GSE53000. Exome sequencing data have been deposited in the European Genome-phenome Archive (EGA) under accession EGAS00001000667.
RCC cell lines engineered: 18 (11 of established cell lines + 7 new from RCC-patient derived primary cell lines).